NCT06636734 2026-02-11
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Emory University
Phase 2 Recruiting
Clinical Trials
10 trialsNCT02964884 2025-06-24
Interventions for Reading Disabilities in NF1
Vanderbilt University
Phase 2 Active not recruiting
NCT03504501 2023-11-30
SynCoRAS
Technical University of Munich
Phase 2 Terminated
NCT00853580 2018-03-12
STARS
University of Alabama at Birmingham
Phase 2 Completed
NCT00585052 2018-01-05
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
University of Iowa
Phase 2 Terminated
NCT00285857 2017-03-09
Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention
Stanford University
Phase 2 Terminated
NCT00580970 2016-11-18
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
Virginia Commonwealth University
Phase 2 Completed
NCT00462280 2014-10-31
Lovastatin in Treating Patients At High Risk of Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00902668 2013-06-20
Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer
Virginia Commonwealth University
Phase 2 Terminated
NCT00963664 2009-09-09
Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
NeoPlas Innovation
Phase 2 Withdrawn